Form 8.3 filing shows 9,585,577 5p ordinary shares held for discretionary clients as of July 29, 2026, alongside a sale of 1,475 shares at 280.1 pence.
Canaccord Genuity Wealth Limited disclosed an interest of 9,585,577 5p ordinary shares in Advanced Medical Solutions Group plc, representing 4.3413% of the company, in a Form 8.3 filing under Rule 8.3 of the Takeover Code. The position was held for discretionary clients as of July 29, 2026. The disclosure also reported a sale of 1,475 shares at 280.1 pence. No cash-settled derivatives, stock-settled derivatives, other dealings, indemnity arrangements, or options-related agreements were disclosed, and no Supplemental Form 8 for open positions was attached. Rule 8.3 disclosures are required when a person holds interests in relevant securities representing 1% or more during an offer period, giving the market visibility into positions and trading by significant holders.